These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29651290)

  • 1. Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease.
    Steiger S; Grill JF; Ma Q; Bäuerle T; Jordan J; Smolle M; Böhland C; Lech M; Anders HJ
    Front Immunol; 2018; 9():619. PubMed ID: 29651290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Background but Not Intestinal Microbiota After Co-Housing Determines Hyperoxaluria-Related Nephrocalcinosis in Common Inbred Mouse Strains.
    Ma Q; Grigorescu M; Schreiber A; Kettritz R; Lindenmeyer M; Anders HJ; Steiger S
    Front Immunol; 2021; 12():673423. PubMed ID: 33968083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
    Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
    Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Anders HJ; Suarez-Alvarez B; Grigorescu M; Foresto-Neto O; Steiger S; Desai J; Marschner JA; Honarpisheh M; Shi C; Jordan J; Müller L; Burzlaff N; Bäuerle T; Mulay SR
    Kidney Int; 2018 Mar; 93(3):656-669. PubMed ID: 29241624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis.
    Marengo SR; Chen DH; Evan AP; Sommer AJ; Stowe NT; Ferguson DG; Resnick MI; MacLennan GT
    Urol Res; 2006 Jun; 34(3):200-10. PubMed ID: 16479391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.
    Marschner JA; Mulay SR; Steiger S; Anguiano L; Zhao Z; Boor P; Rahimi K; Inforzato A; Garlanda C; Mantovani A; Anders HJ
    Front Immunol; 2018; 9():2173. PubMed ID: 30319631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fu-Fang-Jin-Qian-Cao herbal granules protect against the calcium oxalate-induced renal EMT by inhibiting the TGF-β/smad pathway.
    Liu WR; Lu HT; Zhao TT; Ding JR; Si YC; Chen W; Hou JB; Gao SY; Dong X; Yu B; Guo ZY; Lu JR
    Pharm Biol; 2020 Dec; 58(1):1115-1122. PubMed ID: 33191819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrostatin‑1 alleviates oxalate‑induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis.
    Xie J; Ye Z; Li L; Xia Y; Yuan R; Ruan Y; Zhou X
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35703358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney injury in response to crystallization of calcium oxalate leads to rearrangement of the intrarenal T cell receptor delta immune repertoire.
    Zhu C; Liang Q; Liu Y; Kong D; Zhang J; Wang H; Wang K; Guo Z
    J Transl Med; 2019 Aug; 17(1):278. PubMed ID: 31438987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
    Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
    Yang X; Liu H; Ye T; Duan C; Lv P; Wu X; Liu J; Jiang K; Lu H; Yang H; Xia D; Peng E; Chen Z; Tang K; Ye Z
    Theranostics; 2020; 10(26):12011-12025. PubMed ID: 33204326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
    Li Y; McMartin KE
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.
    Khamchun S; Sueksakit K; Chaiyarit S; Thongboonkerd V
    J Biol Inorg Chem; 2019 Mar; 24(2):235-246. PubMed ID: 30701361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease.
    Ma Q; Steiger S; Anders HJ
    Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28364032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway.
    Liu H; Ye T; Yang X; Liu J; Jiang K; Lu H; Xia D; Peng E; Chen Z; Sun F; Tang K; Ye Z
    EBioMedicine; 2019 Dec; 50():366-378. PubMed ID: 31735555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrocalcinosis in animal models with and without stones.
    Khan SR
    Urol Res; 2010 Dec; 38(6):429-38. PubMed ID: 20658131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.
    Mulay SR; Kulkarni OP; Rupanagudi KV; Migliorini A; Darisipudi MN; Vilaysane A; Muruve D; Shi Y; Munro F; Liapis H; Anders HJ
    J Clin Invest; 2013 Jan; 123(1):236-46. PubMed ID: 23221343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.
    Mulay SR; Eberhard JN; Desai J; Marschner JA; Kumar SV; Weidenbusch M; Grigorescu M; Lech M; Eltrich N; Müller L; Hans W; Hrabě de Angelis M; Vielhauer V; Hoppe B; Asplin J; Burzlaff N; Herrmann M; Evan A; Anders HJ
    J Am Soc Nephrol; 2017 Mar; 28(3):761-768. PubMed ID: 27612997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis.
    Ye Z; Xia Y; Li L; Li B; Chen L; Yu W; Ruan Y; Rao T; Zhou X; Cheng F
    Biomed Pharmacother; 2023 Aug; 164():114925. PubMed ID: 37236026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.